CEFTRAX TZ 1.125
CEFTRAX TZ 1.125

CEFTRAX TZ 1.125

Price 242.0 INR/ Vial

MOQ : 50 Pieces

CEFTRAX TZ 1.125 Specification

  • Drug Type
  • Injection
  • Ingredients
  • Brand Name: CEFTRAX 1.125 TZ Generic Name / Content: Ceftriaxone + Tazobactam Injection I.P. 1.125 g Company: Aurobindo Pharma Ltd CEFTRAX 1.125 TZ Injection is a combination antibiotic containing Ceftriaxone (a third-generation cephalosporin) and Tazobactam (a beta-lactamase inhibitor). This dual-action formulation provides broad-spectrum antibacterial activity, including efficacy against beta-lactamase producing bacteria. Ceftriaxone inhibits bacterial cell wall synthesis, while Tazobactam prevents enzymatic degradation of the antibiotic, enhancing overall effectiveness. This sterile injectable formulation is suitable for intravenous (IV) or intramuscular (IM) administration in hospitals and clinical settings. Indications Severe respiratory tract infections (pneumonia, bronchitis, sinusitis) Urinary tract infections (UTIs) Skin and soft tissue infections Bone and joint infections Intra-abdominal infections Septicemia and bacteremia Gynecological infections Surgical prophylaxis Key Features Third-generation cephalosporin combined with a beta-lactamase inhibitor Broad-spectrum antibacterial coverage Effective against resistant bacterial strains Sterile injectable formulation for IV or IM use Manufactured by Aurobindo Pharma Ltd Dosage Form & Category Dosage Form: Injection (Vial) Category: Injectable / Parenteral Antibiotic Strength: 1.125 g per vial Content: Ceftriaxone + Tazobactam Packaging & Storage Supplied in sterile vial packaging Store in a cool, dry place below 25 C Protect from light Use under qualified medical supervision
  • Physical Form
  • Liquid
  • Dosage
  • As Per Suggestion
  • Dosage Guidelines
  • As Per Suggestion
  • Quantity
  • 50 Pieces
  • Storage Instructions
  • Cool & Dry Place
 

CEFTRAX TZ 1.125 Trade Information

  • Minimum Order Quantity
  • 50 Pieces
  • Payment Terms
  • Cash in Advance (CID)
  • Supply Ability
  • 5000 Pieces Per Month
  • Delivery Time
  • 7 Days
  • Main Domestic Market
  • All India
 

About CEFTRAX TZ 1.125

Brand Name: CEFTRAX 1.125 TZ
Generic Name / Content: Ceftriaxone + Tazobactam Injection I.P. 1.125 g
Company: Aurobindo Pharma Ltd

CEFTRAX 1.125 TZ Injection is a combination antibiotic containing Ceftriaxone (a third-generation cephalosporin) and Tazobactam (a beta-lactamase inhibitor). This dual-action formulation provides broad-spectrum antibacterial activity, including efficacy against beta-lactamaseproducing bacteria.

Ceftriaxone inhibits bacterial cell wall synthesis, while Tazobactam prevents enzymatic degradation of the antibiotic, enhancing overall effectiveness. This sterile injectable formulation is suitable for intravenous (IV) or intramuscular (IM) administration in hospitals and clinical settings.

Indications

         Severe respiratory tract infections (pneumonia, bronchitis, sinusitis)

         Urinary tract infections (UTIs)

         Skin and soft tissue infections

         Bone and joint infections

         Intra-abdominal infections

         Septicemia and bacteremia

         Gynecological infections

         Surgical prophylaxis

Key Features

         Third-generation cephalosporin combined with a beta-lactamase inhibitor

         Broad-spectrum antibacterial coverage

         Effective against resistant bacterial strains

         Sterile injectable formulation for IV or IM use

         Manufactured by Aurobindo Pharma Ltd

Dosage Form & Category

         Dosage Form: Injection (Vial)

         Category: Injectable / Parenteral Antibiotic

         Strength: 1.125 g per vial

         Content: Ceftriaxone + Tazobactam

Packaging & Storage

         Supplied in sterile vial packaging

         Store in a cool, dry place below 25C

         Protect from light

         Use under qualified medical supervision

Tell us about your requirement
product

Price:

Quantity
Select Unit

  • 50
  • 100
  • 200
  • 250
  • 500
  • 1000+
Additional detail
Mobile number

Email

More Products in Anaesthetics Injection Category

AXIFUR-H 1.5G

AXIFUR-H 1.5G

Price 68.4 INR / Piece

Minimum Order Quantity : 50 Pieces

Quantity : 1.5g

Ingredients : Cefuroxime and Sulbactam Injection

Drug Type : Other, Allopathic

Storage Instructions : Store in a cool, dry & dark place

AXIFUR 1.5G INJECTION

AXIFUR 1.5G INJECTION

Price 283.0 INR / Pair

Minimum Order Quantity : 50 Pairs

Quantity : 1 vial Boxes

Ingredients : Brand Name: AURACT 1 G Injection Generic Name / Content: Ceftriaxone Sodium Injection I.P. 1 AURACT 1 G Injection contains Ceftriaxone Sodium, a thirdgeneration cephalosporin antibiotic with broadspectrum activity against Grampositive and Gramnegative bacteria. It is widely used for the treatment of serious bacterial infections in hospital and clinical settings. Ceftriaxone works by inhibiting bacterial cell wall synthesis, leading to bacterial death. This injectable formulation is suitable for intravenous (IV) or intramuscular (IM) administration under medical supervision. Indications Respiratory tract infections (pneumonia, bronchitis) Urinary tract infections (UTIs) Skin and soft tissue infections Septicemia and bacteremia Bone and joint infections Meningitis Gonorrhea and other sexually transmitted infection Key Features Thirdgeneration cephalosporin antibiotic Broadspectrum antibacterial activity Rapid and effective action Sterile injectable form for IV or IM use Suitable for adults and pediatric patients (as prescribed) Dosage Form & Category Dosage Form: Injection (Vial / Ampoule) Category: Injectable / Parenteral Strength: 1 g per vial Content: Ceftriaxone Sodium I.P. Packaging & Storage Supplied in sterile vials Store in a cool, dry place below 25 C Protect from light Use under qualified medical supervision

Drug Type : Injection

Storage Instructions : Store in a cool and dry place

LINTAZ 4.5GM

LINTAZ 4.5GM

Price 95.0 INR / Piece

Minimum Order Quantity : 50 Pieces

Quantity : 50 Pieces

Ingredients : Brand Name: LINTAZ 4.5 G Generic Name / Content: Piperacillin + Tazobactam Injection I.P. 4.5 g Company: Aurobindo Pharma Ltd LINTAZ 4.5 G Injection is a broadspectrum injectable antibiotic combining Piperacillin (a penicillinclass antibiotic) and Tazobactam (a betalactamase inhibitor). This dualaction formulation provides enhanced efficacy against betalactamase producing bacteria, covering a wide range of Grampositive and Gramnegative infections. Piperacillin disrupts bacterial cell wall synthesis, while Tazobactam prevents enzymatic degradation, ensuring stronger antibacterial activity. The sterile injectable form is intended for intravenous (IV) or intramuscular (IM) administration in hospitals and clinical settings. Indications Severe respiratory tract infections (pneumonia, bronchitis) Urinary tract infections (UTIs) Skin and soft tissue infections Intraabdominal infections Septicemia and bacteremia Gynecological infections Surgical prophylaxis Key Features Broadspectrum penicillin with betalactamase inhibitor Effective against resistant bacterial strains Rapid and reliable antibacterial action Sterile injectable formulation suitable for hospital use Manufactured by Aurobindo Pharma Ltd Dosage Form & Category Dosage Form: Injection (Vial) Category: Injectable / Parenteral Antibiotic Strength: 4.5 g per vial Content: Piperacillin + Tazobactam Packaging & Storage Supplied in sterile vial packaging Store in a cool, dry place below 25 C Protect from light Use under qualified medical supervision

Drug Type : Injection

Storage Instructions : Cool & Dry Place

AMIVA 250MG

AMIVA 250MG

Price 44.04 INR / Piece

Minimum Order Quantity : 50 Pieces

Quantity : 50 Boxes

Ingredients : Brand Name: AMIVA 250 Generic Name / Content: Amikacin Sulphate Injection I.P. 250 mg AMIVA 250 contains Amikacin Sulphate, a broadspectrum aminoglycoside antibiotic used for the treatment of serious bacterial infections. It works by inhibiting bacterial protein synthesis, effectively killing or stopping the growth of susceptible bacteria. This formulation is intended for intramuscular (IM) or intravenous (IV) administration in hospitals and clinical settings. Indications Severe urinary tract infections (UTIs) Respiratory tract infections (pneumonia, bronchitis) Septicemia and bacteremia Intraabdominal infections Skin and soft tissue infections Bone and joint infections Key Features Broadspectrum aminoglycoside antibiotic Fastacting injectable formulation Suitable for adults and pediatric patients under supervision Highquality sterile preparation Dosage Form & Category Dosage Form: Injection (Vial / Ampoule) Category: Injectable / Parenteral Strength: 250 mg per vial/ampoule



Back to top